SCHEMBL16409598

SCHEMBL16409598

c1ccc2c(c1)sc1cc(-n3c4ccccc4c4ccc(-n5c6ccccc6c6ccccc65)cc43)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GPR3 P46089 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ATM Q13315 2/20 0.46
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HSD17B10 Q99714 1/20 0.34
TP53 P04637 1/20 0.32
ALOX15 P16050 1/20 0.32
RXFP1 Q9HBX9 2/20 0.32
CYP1A2 P05177 1/20 0.31
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31
PRSS1 P07477 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15462289 0.97 MAPT (0.50) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL20232371 0.95 MAPT (0.49) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL12114930 0.93 L3MBTL1 (0.52) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL27428319 0.93 ATM (0.51) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17246305 0.92 MAPT (0.44) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17246531 0.92 MAPT (0.44) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL10450790 0.92 MAPT (0.46) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL16398137 0.92 GPR3 (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL16409593 0.92 GPR3 (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17189517 0.92 MAPT (0.46) MAPTALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363272-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-09 US disclosed
US-20230363272-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-09 US disclosed
WO-2015009102-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME 주식회사 두산 (KR) 2015-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230363272-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME LAGE3, CRY1, CRY2 MAPT 2702/4885ALDH1A1 42/4885HPGD 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.